LabConnect, a leading global provider of central laboratory and support
services for biopharmaceutical, pharmaceutical, medical device, and contract research organizations,
has appointed Dr. Anthony Todd Everhart to serve as medical director. At LabConnect, Dr. Everhart’s
primary duties will be to serve as medical liaison to central laboratory medical directors, expanding the
use of visual analytics, and advising Data Management and Scientific Affairs on data integration, data
normalization, and data harmonization. He will contribute a wealth of industry skills and experience to
LabConnect and his appointment will bring yet another level of valuable expertise for the clients of
LabConnect’s premium central lab services.
According to LabConnect’s Chairman, Eric Richman, “Dr. Everhart’s expertise is medical monitoring and
clinical data review for complex studies with experience in management of over 30 clinical trials.
In this era of ever-increasing data, his focus has been on medical data review using visual analytics to ensure
and optimize data quality. We welcome his expertise in technology adoption and in developing
methodologies and tools for technology implementation.
Dr. Everhart is an innovator, educator, and leader in the pharmaceutical and biotechnology industries,
bringing over 11 years of experience in complex clinical development to LabConnect. Prior to joining, he
served as vice president of medical informatics at Chiltern/Covance, vice president of medical affairs
Americas at Chiltern, and medical director at Clinical Trial Management Services (CTMS). Board-certified
in internal medicine and a fellow of the American College of Physicians, he has worked in all phases of
clinical development in numerous therapeutic areas including allergy and immunology, cardiovascular,
hematology and oncology, infectious disease and HIV, neurology, ophthalmology, psychiatry,
respiratory, and rheumatology.